263 related articles for article (PubMed ID: 16731821)
1. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells.
Li X; Chen H; Epstein PN
Diabetes; 2006 Jun; 55(6):1592-604. PubMed ID: 16731821
[TBL] [Abstract][Full Text] [Related]
2. The combination of metallothionein and superoxide dismutase protects pancreatic β cells from oxidative damage.
Park L; Min D; Kim H; Park J; Choi S; Park Y
Diabetes Metab Res Rev; 2011 Nov; 27(8):802-8. PubMed ID: 22069263
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
Augstein P; Elefanty AG; Allison J; Harrison LC
Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
[TBL] [Abstract][Full Text] [Related]
4. Protection of insulin-producing cells against toxicity of dexamethasone by catalase overexpression.
Roma LP; Bosqueiro JR; Cunha DA; Carneiro EM; Gurgul-Convey E; Lenzen S; Boschero AC; Souza KL
Free Radic Biol Med; 2009 Nov; 47(10):1386-93. PubMed ID: 19698781
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide gene therapy suppresses reactive oxygen species in the pancreas and prevents mice from autoimmune diabetes.
She F; Sun W; Mao JM; Wang X
Sheng Li Xue Bao; 2003 Dec; 55(6):625-32. PubMed ID: 14695477
[TBL] [Abstract][Full Text] [Related]
6. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
[TBL] [Abstract][Full Text] [Related]
7. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
[TBL] [Abstract][Full Text] [Related]
9. Prevention of type 1 diabetes: from the view point of beta cell damage.
Kawasaki E; Abiru N; Eguchi K
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S27-32. PubMed ID: 15563975
[TBL] [Abstract][Full Text] [Related]
10. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
[TBL] [Abstract][Full Text] [Related]
11. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor: a new player associated with apoptosis and proliferation of pancreatic beta-cell in type 1 diabetes mellitus.
Li RJ; Qiu SD; Wang HX; Tian H; Wang LR; Huo YW
Apoptosis; 2008 Aug; 13(8):959-71. PubMed ID: 18543106
[TBL] [Abstract][Full Text] [Related]
13. Modulation of intracellular reactive oxygen species level in chondrocytes by IGF-1, FGF, and TGF-beta1.
Jallali N; Ridha H; Thrasivoulou C; Butler P; Cowen T
Connect Tissue Res; 2007; 48(3):149-58. PubMed ID: 17522998
[TBL] [Abstract][Full Text] [Related]
14. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats.
Anwer T; Sharma M; Pillai KK; Haque SE; Alam MM; Zaman MS
Toxicology; 2007 Jan; 229(1-2):165-72. PubMed ID: 17145126
[TBL] [Abstract][Full Text] [Related]
17. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
18. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
19. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways.
Manna P; Sinha M; Sil PC
Toxicology; 2009 Mar; 257(1-2):53-63. PubMed ID: 19133311
[TBL] [Abstract][Full Text] [Related]
20. The non-peptidyl low molecular weight radical scavenger IAC protects human pancreatic islets from lipotoxicity.
D'Aleo V; Del Guerra S; Martano M; Bonamassa B; Canistro D; Soleti A; Valgimigli L; Paolini M; Filipponi F; Boggi U; Del Prato S; Lupi R
Mol Cell Endocrinol; 2009 Oct; 309(1-2):63-6. PubMed ID: 19481137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]